Cloperastine fendizoate
Cloperastine fendizoate (Hustazol) is a potent, concentration-dependent inhibitor of the hERG potassium channel, with an IC50 of 27 nM. This property makes it a valuable pharmacological tool for in vitro cardiac safety research and studies of long QT syndrome mechanisms.
Product Specifications
CAS Number
85187-37-7
Product Name Alternative
Cloperastine fendizoate, hERG Potassium Channel, Hustazol, K+ currents
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.85% (May vary between batches)
Solubility
DMSO:8 mg/mL (12.34 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.54 mM)
Smiles
Clc1ccc (cc1) C (OCCN1CCCCC1) c1ccccc1.OC (=O) c1ccccc1C (=O) c1ccc (O) c (c1) -c1ccccc1
Molecular Formula
C40H38ClNO5
Molecular Weight
648.19
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
041301-ML550 100 µL
RSPO2, CT (RSPO2, R-spondin-2, Roof plate-specific spondin-2) (MaxLight 550) discontinued
Sign In for Pricing
View Details 
![[3- (Hydroxymethyl) quinolin-2-yl]methanol](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
NBP2-81756CL1 0.1 mL
Rabbit Polyclonal Patched Domain Containing 2 Antibody [CoraFluor 1]
Sign In for Pricing
View Details